Ameriprise’s Allergan Inc AGN Stock Holding History

Ameriprise’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-183,086	Closed	-$38.9M	–	4047
2014 Q4	$38.9M	Buy	183,086 +53,598	+41%	+$10.7M	0.02%	619
2014 Q3	$23.1M	Sell	129,488 -2,410	-2%	-$400K	0.01%	865
2014 Q2	$22.3M	Sell	131,898 -12	-0%	-$1.87K	0.01%	976
2014 Q1	$16.4M	Sell	131,910 -3,985,237	-97%	-$485M	0.01%	1145
2013 Q4	$457M	Buy	4,117,147 +385,461	+10%	+$36.8M	0.28%	81
2013 Q3	$338M	Buy	3,731,686 +58,202	+2%	+$5.22M	0.22%	104
2013 Q2	$309M	Buy	+3,673,484	New	+$381M	0.21%	104

Other funds holding AGN

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return

ECM

Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return

HFS

HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Ameriprise's AGN Position: Q1 2015 in Review

Ameriprise sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 183,086 shares — an estimated $38.9M sold.

Ameriprise first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $457M in Q4 2013. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

Ameriprise reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
Ameriprise sold 183,086 Allergan Inc shares in Q1 2015, an estimated $38.9M.
Ameriprise first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
Ameriprise's Allergan Inc position peaked at $457M in Q4 2013.
5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Ameriprise's 13F filing for Q1 2015, filed 14 May 2015.